AFAIK Israel over paid by 200% for the first million vaccines. So it might have gotten "more than its fair share" (Israel is ~8M, so ~1% of the developed world population).
BUT then, due to the population density and centralized nature, it was able to roll out this million very efficiently, within a week, with relative efficiency. With about 80% going to over-60, vulnerable or essential-personel.
Setting it up for this special deal, as a "test case nation". It also seems this deal was reached without any regulatory or parliamentary overview.
BUT then, due to the population density and centralized nature, it was able to roll out this million very efficiently, within a week, with relative efficiency. With about 80% going to over-60, vulnerable or essential-personel.
Setting it up for this special deal, as a "test case nation". It also seems this deal was reached without any regulatory or parliamentary overview.